![](/image/dgray01.gif) |
Recent Advance and Challenges in Molecular Targeted Therapy for Cancers--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Overview of Molecular Targeted Therapy in Oncology
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Reimbursement for Molecular Targeted Therapy of Cancer Patients -- Will There be A Solution?
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance in Target Therapy in Rheumatic Diseases--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
TNF-a Target Therapy
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
B cell Target Therapy
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Co-stimulatory Molecule Target Therapy
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Novel Cytokine/Cytokine Receptor Target Therapy
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
治療血脂異常的新進展--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Optimizing CVD Prevention: LDL-C Lowering and HDL-C Elevation
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Holy Grail or Double Edged Blade: Statins for Hyperlipidemia, CVD and Cancer
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
敗血症治療新進展--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
敗血症治療新進展
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
早期消化道癌症之診治新進展--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
早期胃癌之內視鏡診斷
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
早期胃癌之內視鏡治療
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
早期胃癌之病理診斷
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance in Multidetector Coronary Angiography--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance of MDCT
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
How to apply MDCT in Clinical Practice?
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
MDCT, Thallium 201 Perfusion Scan, Stress Echocardiography, Which is Better?
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
睡眠呼吸障礙之診治新進展--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
在睡眠呼吸終止症患者中陽壓呼吸器效果的預測與評估
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
耳鼻喉科評估與睡眠呼吸終止相關性
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
下顎位置影響口咽軟組織於呼吸時之行為
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance in IgE and Anti-IgE for Internal Medicine Doctors: Past, Present, and Future--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
IgE and Anti-IgE:Past, Present and Future
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Anti-IgE in Bronchial Asthma
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance in Cell Therapy in Hematology--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Adoptive Cellular Immunotherapy in Leukemia and Hematopoietic Stem Cell Transplantation
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Adoptive Cellular Immunotherapy in Viral Infection
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Graft Versus Tumor Effects in the Treatment of Hematological Malignancies
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
The role of Mesenchymal Stem Cells in the Treatment of Hematological Diseases
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance in Allergen Immunotherapy: Injection, Sublingual or Food?--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
口服耐受性與免疫療法
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
舌下減敏療法
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
免疫療法介紹(包括注射)
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Recent Advance in Drug Eluting Stents--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Limus-Eluting Stents(Cypher, Endeavor, Xience V)
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Paclitaxel-Eluting Stents(Taxus etc), and Issue of DES Thrombosis
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Next Generation DES(Genous, Biodegradable, Bioabsorable Stents)
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
糖尿病用藥的新進展--引言
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Current anti-diabetic therapy in Taiwan
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
GLP-1:an alternative approach for type 2 DM
![](/image/pdf02.gif) |
![](/image/dgray01.gif) |
Shifts in Treatment Paradigms of Type 2 Diabetes: Incretin Enhancers are Coming
![](/image/pdf02.gif) |